Leadership
Management Team
Sona Nanotech’s unique gold nanorods have the potential to power the next generation of lateral flow diagnostics. The company’s leadership team plays a crucial role in the advancement of impactful cancer therapies & rapid diagnostics.
David Regan
CEO
- Business and commercial operations oversight.
- Strategy consultant and corporate director.
- 15 years public company experience in strategy, IR and corporate development.
- MBA from INSEAD and BBA (Hons) from St. FXU.
Len Pagliaro, PhD
CSO
- Prof. of Bioengineering & Laboratory Medicine at University of Washington.
- 24yrs exp with biotechnology products, services, & technology licensing.
- Developed commercialization at BioImage from concept to a $26M P&L in 4 yrs, leading to acquisition & integration by ThermoFisher Scientific.
- As CEO of Dynamic Light, Inc. led the spinout of an academic team from concept to first revenues in under 3 years.
Dr. Carman Giacomantonio, MD MSc FRCSC
CMO
- Surgical oncologist and professor of surgery
- Researcher with focus on cancer metastases: breast, melanoma, colorectal cancer
- Studying the mechanism of action of interleukin-2 therapy in the treatment of melanoma and other cancers
- Principal investigator on Sona’s study evaluating the efficacy of Sona’s technology
Darren Rowles
Head of Diagnostics
- 17 years' experience with nanoparticle diagnostics.
- MBA from Bath University and BSc in Biomedical Science and Toxicology from UWIC.
Kulbir Singh, PhD
Co-Founder & Head of GNR R&D
- Responsible for GNR development.
- Named author on 35 research papers and 2 patents.
- PhD in chemistry from Guru Nanak Dev University.
- Co-founder of a sciencebased, consumer product company.
Robert Randall, CPA
Chief Financial Officer
- Extensive public company experience as CFO Torrent Capital, Antler Gold and eXeBlock Technology.
- B.Comm. from St. Mary’s University with CA designation in 1987 with Coopers and Lybrand Chartered Accountants.
